%
Delivering high-quality, FDA-compliant clinical research.
We combine Australian excellence with global reach to deliver exceptional clinical research outcomes that drive innovation forward.
Australian expertise combined with direct FDA submission capabilities, offering a streamlined path for global approval.
Every dollar is strategically allocated, eliminating unnecessary costs while maintaining the highest quality.
Access high-quality trials in the Asia-Pacific region, enhancing speed and scalability.
Engage directly with our team of highly qualified doctors and PhD scientists from the outset.
Discover how we’re making innovative treatments accessible worldwide
We collaborate with trusted partners to deliver exceptional quality and service.
Our core mission is to create access to high-quality clinical research globally by removing financial and other unnecessary barriers.
We believe that innovative treatments should have a clear path to market, regardless of the size of the company developing them. By providing cost-effective, high-quality clinical research services, we enable biotech firms to bring life-changing therapies to patients worldwide.
“We have been using iNGENū for a Phase 1, first-in-human clinical trial of our breakthrough drug. We have been nothing but impressed by their R&D and GCP knowledge, clinical capability, project management, clinical data management, and also their very friendly way of managing, and explaining the data, clinical trial, and also how to do a clinical trial that just explained it in a very user-friendly format.”
Giles Moss
Chief Executive Officer
Ready to accelerate your clinical research journey?